Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat
- PMID: 2991964
- DOI: 10.1007/BF00431705
Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat
Abstract
The behavioural effects of systemic and intrastriatal injections of the dopamine agonists piribedil and apomorphine in male rats were examined. Bilateral application of piribedil (50 and 100 micrograms) or apomorphine (5, 10 and 20 micrograms) to the striatum produced yawning and chewing mouth movements accompanied by intermittent stretching and sexual arousal. Low doses of piribedil (1.25 and 2.5 mg/kg) and apomorphine (0.1 and 0.2 mg/kg) injected SC produced an identical yawning syndrome. Previous work has suggested that yawning elicited by systemic dopamine agonist treatment is a consequence of dopamine autoreceptor stimulation. Similarly, the most likely explanation of the present data is that yawning elicited by systemic and central dopamine agonist treatment was due to activation of dopamine autoreceptors. Systemic injection of haloperidol and scopolamine abolished yawning induced by intrastriatal piribedil and these data provide tentative support for the proposal that a dopamine-acetylcholine link may be involved in the expression of yawning.
Similar articles
-
Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats.Psychopharmacology (Berl). 1986;90(1):9-13. doi: 10.1007/BF00172863. Psychopharmacology (Berl). 1986. PMID: 2945222
-
Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats.Neuropharmacology. 1985 Nov;24(11):1051-5. doi: 10.1016/0028-3908(85)90190-x. Neuropharmacology. 1985. PMID: 3935946
-
Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.Pol J Pharmacol Pharm. 1985 May-Jun;37(3):383-96. Pol J Pharmacol Pharm. 1985. PMID: 2866504
-
Do autoreceptors mediate dopamine agonist--induced yawning and suppression of exploration? A critical review.Psychopharmacology (Berl). 1992;106(1):1-13. doi: 10.1007/BF02253581. Psychopharmacology (Berl). 1992. PMID: 1738786 Review.
-
Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil.J Neurol. 1992;239 Suppl 1:S13-6. doi: 10.1007/BF00819561. J Neurol. 1992. PMID: 1634905 Review.
Cited by
-
Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats.Psychopharmacology (Berl). 1995 Aug;120(4):376-83. doi: 10.1007/BF02245808. Psychopharmacology (Berl). 1995. PMID: 8539317
-
Relation between yawning behavior and central serotonergic neuronal system in rats.Naunyn Schmiedebergs Arch Pharmacol. 1987 Jun;335(6):667-72. doi: 10.1007/BF00166984. Naunyn Schmiedebergs Arch Pharmacol. 1987. PMID: 2957600
-
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.Psychopharmacology (Berl). 1988;95(4):502-6. doi: 10.1007/BF00172963. Psychopharmacology (Berl). 1988. PMID: 2463651
-
Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.Psychopharmacology (Berl). 1987;93(3):336-42. doi: 10.1007/BF00187253. Psychopharmacology (Berl). 1987. PMID: 3124163
-
Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.Br J Pharmacol. 1989 Apr;96(4):843-8. doi: 10.1111/j.1476-5381.1989.tb11893.x. Br J Pharmacol. 1989. PMID: 2663110 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources